zidovudine has been researched along with Encephalopathy, Toxic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Duburs, G; Dzirkale, Z; Gordjushina, V; Isajevs, S; Klusa, V; Kratovska, A; Pilipenko, J; Pupure, J; Rumaks, J; Svirskis, S; Taivans, I | 1 |
Isajevs, S; Kalvinsh, I; Klusa, V; Pupure, J; Rumaks, J; Skapare, E; Svirina, D; Svirskis, S | 1 |
3 other study(ies) available for zidovudine and Encephalopathy, Toxic
Article | Year |
---|---|
Distinct influence of atypical 1,4-dihydropyridine compounds in azidothymidine-induced neuro- and cardiotoxicity in mice ex vivo.
Topics: Animals; Anti-HIV Agents; Apoptosis; Caspase 3; Cerebral Cortex; Dihydropyridines; Gene Expression Regulation; Glutamates; Heart Diseases; Inflammation; Male; Mice; Mice, Inbred ICR; Neurotoxicity Syndromes; Taurine; Transcription Factor RelA; Zidovudine | 2008 |
Neuroprotective properties of mildronate, a mitochondria-targeted small molecule.
Topics: Animals; Anti-HIV Agents; Brain; Caspase 3; Cellular Apoptosis Susceptibility Protein; Disease Models, Animal; Electron Transport Complex IV; Glial Fibrillary Acidic Protein; Lymphocytes; Male; Methylhydrazines; Mice; Mice, Inbred Strains; Neuroprotective Agents; Neurotoxicity Syndromes; Nitric Oxide Synthase Type II; Zidovudine | 2010 |
Neurological disorders after zidovudine exposure in utero.
Topics: Female; France; HIV Infections; Humans; Infant, Newborn; Lamivudine; Mitochondria; Neurotoxicity Syndromes; Pregnancy; Prenatal Exposure Delayed Effects; Retrospective Studies; United States; Zidovudine | 1999 |